List of Netspot drug patents

Netspot is owned by Aaa Usa Inc.

Netspot contains Gallium Dotatate Ga-68.

Netspot has a total of 1 drug patent out of which 0 drug patents have expired.

Netspot was authorised for market use on 01 June, 2016.

Netspot is available in powder;intravenous dosage forms.

The generics of Netspot are possible to be released after 10 August, 2032.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9375498 AAA USA INC Process for the preparation of complexes of 68Ga
Aug, 2032

(9 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Jun 1, 2023

Drugs and Companies using GALLIUM DOTATATE GA-68 ingredient

Market Authorisation Date: 01 June, 2016

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic